Tobacco threatens health, economies and development.
Find out more through the following infographics:
Dr Jacques Raubenheimer, from The University of Sydney, presents Drug Surveillance Using Internet Search Data From Google Trends: What are the Possibilities.
This episode focuses on data released ahead of the first anniversary of the Scottish Government's flagship health policy of minimum unit pricing.
The internet is full of misinformation about recreational drugs - both legal and illegal.
Dr Suzi Gage, a psychologist interested in understanding associations between substance use and mental health, tackles one substance per episode - providing information about what we know - the harms, but also potential benefits of these substances.
Episode 32: Tobacco Industry Watchdogs Soundcloud Podcast
The Collaborate Care Planning Project (COCAPP) studies mental health risk, care planning and therapeutic relationships. This podcast interview with Alan Simpson and Sarah Carr explores the importance of assessing and managing risk, how to make care planning work for staff and service users, and what constitutes a positive therapeutic relationship.
Smoke Signals: what does legalised cannabis mean for mental health?
Chaired by: Ian Hamilton, University of York
Alcohol taxation holds massive potential for global health, for helping achieve the sustainable development goals and also for significantly contributing to financing health and development.
The majority of existing knowledge on patterns of alcohol consumption is based on retrospective-recall methodologies.
These are cost-efficient and convenient but are limited in their capacity to record data on the circumstances of alcohol consumption as they emerge in time and space.
To assist workplaces to respond to alcohol and other drug-related harm in the workplace, The National Centre for Education and Training on Addiction, has produced a series of factsheets about commonly used drugs and their impact on safety and well-being of individual employees, and overall safety and productivity of the workplace.
Fact sheets cover the following topics:
This webinar will present an update on research into co-occurring mental and substance use disorders among young people in Australia.
It will ask:
This webinar provides information about:
People who have experienced serious mental health issues are three times more likely to smoke than the wider population.
This summary, plus infographic, describes the Smoking Cessation Intervention for People with Severe Mental Ill Health trial.
This is a comic created by the Philippines Drug Enforcement Agency to promote Drug Free Workplaces. It is suitable for children.
UNODC has compiled a selection of educational materials and flyers that provide information on drug dependence treatment and care.
The resource has been translated into several languages and covers topics including:
Andrew Tatarsky, Ph.D., Founder and Director The Center for Optimal Living will take us through a harm reduction approach which has compassion at its centre. This webinar looks at harm reduction across the range of risk behaviours associated with problematic use of substances.
This Inside Health podcast discusses why vaping is dividing public health experts causing a polarised split; prehabilitation before cancer surgery and the benefits of preparing for an operation; plus can hospital safety be compared to lessons learnt from the aviation industry?
The Virtual Library in Addictions, developed by centers of youth integration, allows access to resources and information services specialized in Addictions and related topics, serving users of different levels.
El Observatorio Mexicano de Drogas tiene como propósito brindar información objetiva, confiable y comparable a nivel nacional sobre el consumo de sustancias psicoactivas y la demanda de tratamiento por su uso para orientar el diseño de políticas públicas.
Xchange is an online registry of evidence-based prevention programmes. In its first phase, the registry will make available manualised interventions that European evaluation studies show have beneficial outcomes relating to substance use. For programmes of US origin, the registry also provides the evidence level of the evaluation studies conducted there (Blueprint ratings).